Skip to main content
Log in

Dabigatran for stroke prevention in AF worth its cost in Hong Kong?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The researchers point out that dabigatran is a "self-financed item" under the local public health organisation in Hong Kong, meaning that patients have to pay for it themselves.

  2. incremental cost-effectiveness ratios

  3. current price of dabigatran in Hong Kong $1.68 per capsule

Reference

  • Chang AM, et al. Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation - A Real Patient Data Analysis in a Hong Kong Teaching Hospital. Clinical Cardiology : 14 Mar 2013. Available from: URL: http://dx.doi.org/10.1002/clc.22112

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dabigatran for stroke prevention in AF worth its cost in Hong Kong?. PharmacoEcon Outcomes News 675, 6 (2013). https://doi.org/10.1007/s40274-013-0279-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0279-8

Navigation